A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

NCT07438496 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Erythematosus, Systemic

Interventions

DRUG: Nipocalimab
DRUG: Placebo
DRUG: Standard of care treatment

Sponsor

Janssen Research & Development, LLC